Cargando…
Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study
BACKGROUND: Dogs are the definitive hosts of Spirocerca lupi. Spirocercosis is treated by prolonged avermectin administration by injection or daily oral doses. In this prospective, double-blinded, placebo-controlled, clinical trial, the efficacy of imidacloprid and moxidectin spot-on formulation (Ad...
Autores principales: | Segev, Gilad, Rojas, Alicia, Lavy, Eran, Yaffe, Marganit, Aroch, Itamar, Baneth, Gad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838953/ https://www.ncbi.nlm.nih.gov/pubmed/29506575 http://dx.doi.org/10.1186/s13071-018-2731-x |
Ejemplares similares
-
Detection and quantification of Spirocerca lupi by HRM qPCR in fecal samples from dogs with spirocercosis
por: Rojas, Alicia, et al.
Publicado: (2017) -
Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)
por: Le Sueur, Christophe, et al.
Publicado: (2010) -
Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis
por: Heuer, Lea, et al.
Publicado: (2020) -
Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate(®)) for the treatment of Troglostrongylus brevior in naturally infected cats in a field study in Greece
por: Diakou, Anastasia, et al.
Publicado: (2019) -
Effect of Therapy by Using Advocate Spot-On Combination (Imidacloprid 10% and Moxidectin 2.5%) on Subcutaneous Dirofilariosis in Dogs
por: Paran, Radmila Dobešová, et al.
Publicado: (2011)